Mark de Boer
Hoogleraar Infectieziekten, in het bijzonder antimicrobiële resistentie en antibioticabeleid
- Naam
- Prof.dr. M.G.J. de Boer MD
- Telefoon
- +31 71 526 2613
- m.g.j.de_boer@lumc.nl
- ORCID iD
- 0000-0002-5009-6499
Hoogleraar Infectieziekten, in het bijzonder antimicrobiële resistentie en antibioticabeleid
- Faculteit Geneeskunde
- Divisie 2
- Infectieziekten
Contact
- Leegwater, E.; Baidjoe, L.; Wilms, E.B.; Visser, L.G.; Touw, D.J.; Winter, B.C.M. de; Boer, M.G.J. de; Paassen, J. van; Berg, C.H.S.B. van den; Prehn, J. van; Gelder, T. van & Moes, D.J.A.R. (2024), Population pharmacokinetics of trimethoprim/sulfamethoxazole, Clinical Pharmacology & Therapeutics.
- Hanssen, J.L.J.; Wal, R.J.P. van der; Linden, H.M.J. van der; Prehn, J. van; Scheper, H. & Boer, M.G.J. de (2024), Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study, Journal of Bone and Joint Infection 9(3): 149-159.
- Hanssen, J.L.J.; Gademan, M.G.J.; Wouthuyzen-Bakker, M.; Davis, J.S.; Dewar, D.; Manning, L.; Campbell, D.; Prehn, J. van; Miller, A.O.; Wal, R.J.P. van der; Linden, H.M.J. van der; Cortés-Penfield, N.W.; Soriano, A.; Boer, M.G.J. de & Scheper, H. (2024), Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study, Journal of Infection 89(6).
- Klomp, S.D.; Veringa, A.; Alffenaar, J.W.C.; Boer, M.G.J. de; Span, L.F.R.; Guchelaar, H.J. & Swen, J.J. (2024), Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole, Clinical and Translational Science 17(7).
- Popping, S.; Nichols, B.E.; Appelman, B.; Biemond, J.J.; Vergouwe, M.; Rosendaal, F.R.; Valk, M. van der; Bree, G.J. de; Wiersinga, W.J.; Birnie, E. & Turn-Covid Study Grp (2023), Health outcomes and cost-effectiveness of monoclonal SARS-CoV-2 antibodies as pre-exposure prophylaxis, Jama Network Open 6(7).
- Surial, B.; Mena, A.R.; Roumet, M.; Limacher, A.; Smit, C.; Leleux, O.; Mocroft, A.; Valk, M.V.; Bonnet, F.; Peters, L.; Rockstroh, J.K.; Guenthard, H.F.; Berzigotti, A.; Rauch, A. & Wandeler, G. (2023), External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection, Journal of Hepatology 78(5): 947-957.
- Veringa, A.; Bruggemann, R.J.; Span, L.F.R.; Biemond, B.J.; Boer, M.G.J. de; Heuvel, E.R. van den; Klein, S.K.; Kraemer, D.; Minnema, M.C.; Prakken, N.H.J.; Rijnders, B.J.A.; Swen, J.J.; Verweij, P.E.; Wondergem, M.J.; Ypma, P.F.; Blijlevens, N.; Kosterink, J.G.W.; Werf, T.S. van der; Alffenaar, J.W.C. & Voriconazole ZonMw Study Grp (2023), Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients, International Journal of Antimicrobial Agents 61(2).
- Dun, S.C.J. van; Verheul, M.; Pijls, B.G.C.W.; Prehn, J. van; Scheper, H.; Galli, F.; Nibbering, P.H. & Boer, M.G.J. de (2023), Influence of surface characteristics of implant materials on MRSA biofilm formation and effects of antimicrobial treatment, Frontiers in Microbiology 14.
- Gerritsen, L.M.; Scheper, H.; Boer, M.G.J. de; Schoones, J.W.; Nelissen, R.G.H.H. & Pijls, B.G.C. (2023), Outcome of debridement, antibiotics and implant retention for streptococcal hip and knee prosthetic joint infections, SURGERY IN PRACTICE AND SCIENCE 14.
- Grootveld, R. van; Masarotto, V.; Borne, P.A. von dem; Blijlevens, N.M.A.; Chitu, D.A.; Beek, M.T. van der; Fiocco, M. & Boer, M.G.J. de (2023), Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome, BMC Infectious Diseases 23(1).
- Welling, M.M.; Warbroek, K.; Khurshid, C.; Oosterom, M.N. van; Rietbergen, D.D.D.; Boer, M.G.J. de; Nelissen, R.G.H.H.; Leeuwen, F.W.B. van; Pijls, B.G. & Buckle, T. (2023), A radio- and fluorescently labelled tracer for imaging and quantification of bacterial infection on orthopaedic prostheses, Bone & Joint Research 12(1): 72-79.
- Westgeest, A.C.; Ruffin, F.; Kair, J.L.; Park, L.P.; Korn, R.E.; Webster, M.E.; Visser, L.G.; Schippers, E.F.; Boer, M.G.J. de; Lambregts, M.M.C. & Fowler, V.G. .J.r. (2023), The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia, Clinical Microbiology and Infection 29(9): 1182-1187.
- Leegwater, E.; Dol, L.; Benard, M.R.; Roelofsen, E.E.; Delfos, N.M.; Feltz, M. van der; Mollema, F.P.N.; Bosma, L.B.E.; Visser, L.E.; Ottens, T.H.; Burgel, N.D. van; Arbous, S.M.; Bouazzaoui, L.H. el; Knevel, R.; Groenwold, R.H.H.; Boer, M.G.J. de; Visser, L.G.; Rosendaal, F.R.; Wilms, E.B. & Nieuwkoop, C. van (2023), Rapid response to remdesivir in hospitalised COVID-19 patients: A propensity score weighted multicentre cohort study, Infectious Diseases and Therapy 12(10): 2471-2484.
- Droogh, D.H.M.; Groen, J.V.; Boer, M.G.J. de; Prehn, J. van; Putter, H.; Bonsing, B.A.; Eijck, C.H.J. van; Vahrmeijer, A.L.; Santvoort, H.C. van; Koerkamp, B.G. & Mieog, J.S.D. (2023), Prolonged antibiotic prophylaxis after pancreatoduodenectomy, British Journal of Surgery 110(11).
- Brunink, E.M.; Hoogervorst, L.A.; Steentjes, K.; Broekhuis, D. & Boer, M.G.J. de (2023), Osteomyelitis caused by Streptococcus intermedius in immunocompetent adults - a case report and systematic literature review, European Journal of Clinical Microbiology and Infectious Diseases 42(9): 1055-1061.
- Wijnakker, R.; Maaren, M.S. van; Bode, L.G.M.; Bulatovic, M.; Hendriks, B.J.C.; Loogman, M.C.M.; Lutgens, S.P.M.; Middel, A.; Nieuwhof, C.M.G.; Roelofsen, E.E.; Schoones, J.W.; Sigaloff, K.C.E.; Sprikkelman, A.B.; Vrankrijker, L.M.M. de & Boer, M.G.J. de (2023), The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy, Clinical Microbiology and Infection 29(7): 863-875.
- Droogh, D.H.M.; Dam, J.L. van; Groen, J.V.; Boer, M.G.J. de; Prehn, J. van; Eijck, C.H.J. van; Bonsing, B.A.; Vahrmeijer, A.L.; Koerkamp, B.G. & Mieog, J.S.D. (2023), Prolonged antibiotics after pancreatoduodenectomy reduce abdominal infections in patients with positive bile cultures, HPB 25(9): 1056-1064.
- Scheper, H.; Mahdad, R.; Elzer, B.; Löwik, C.; Zijlstra, W.; Gosens, T.; Lugt, J.C.T. van der; Wal, R.J.P. van der; Poolman, R.W.; Somford, M.P.; Jutte, P.C.; Bos, P.K.; Zwaan, R.E.; Nelissen, R.G.H.H.; Visser, L.G.; Boer, M.G.J. de & Wound Care App Study Grp (2023), Wound drainage after arthroplasty and prediction of acute prosthetic joint infection, Journal of Bone and Joint Infection 8(1): 59-70.
- Westgeest, A.C.; Buis, D.T.P.; Sigaloff, K.C.E.; Ruffin, F.; Visser, L.G.; Yu, Y.S.; Schippers, E.F.; Lambregts, M.M.C.; Tong, S.Y.C.; Boer, M.G.J. de & Fowler, V.G. (2023), Global differences in the management of Staphylococcus aureus bacteremia, Clinical Infectious Diseases 77(8).
- Swets, M.C.; Moss, R.J.; Kor, F.; Hilarius, D.; Moes, D.J.A.R.; Berkhout, W.E.; Toorn, L.M. van den; Oever, N.C.G. van den; Valk, R. de; Rosendaal, F.R.; Hunfeld, N.; Groeneveld, G.H. & Boer, M.G.J. de (2023), A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19, International Journal of Infectious Diseases 129: 57-62.
- Buis, D.T.P.; Werkhoven, C.H. van; Agtmael, M.A. van; Bax, H.I.; Berrevoets, M.; Boer, M.G.J. de; Bonten, M.J.M.; Bosmans, J.E.; Branger, J.; Douiyeb, S.; Gelinck, L.B.S.; Jong, E.; Lammers, A.J.J.; Meer, J.T.M. van der; Oosterheert, J.J.; Sieswerda, E.; Soetekouw, R.; Stalenhoef, J.E.; Vaart, T.W. van der; Vaate, E.A.B. de; Verkaik, N.J.; Vonderen, M.G.A. van; Vries, P.J. de; Prins, J.M.; Sigaloff, K.C.E. & Collaborators SAFE-Trial Study Grp (2023), Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial), BMJ Open 13(4).
- Sijbom, M.; Buchner, F.L.; Saadah, N.H.; Numans, M.E. & Boer, M.G.J. de (2023), Trends in antibiotic selection pressure generated in primary care and their association with sentinel antimicrobial resistance patterns in Europe, Journal of Antimicrobial Chemotherapy 78(5).
- Boer, M. G. J. de; Bonten, M. J. M. & Huckriede, A. L. W. (2022), Een vooruitblik op covid-19-vaccinatie en -behandeling, Nederlands Tijdschrift voor Geneeskunde 166.
- Moes, D.J.A.R.; Westerloo, D.J. van; Arend, S.M.; Swen, J.J.; Vries, A. de; Guchelaar, H.J.; Joosten, S.A.; Boer, M.G.J. de; Gelder, T. van & Paassen, J. van (2022), Towards fixed dosing of tocilizumab in ICU-admitted COVID-19 patients, Clinical Pharmacokinetics 61.
- Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Visser, L.G.; Fijter, J.W. de; Boer, M.G.J. de & Lambregts, M.M.C. (2022), Acute kidney injury in Staphylococcus aureus bacteremia, European Journal of Clinical Microbiology and Infectious Diseases 41.
- Leuning, D.G.; Groeneveld, G.H.; Appelman, B.; Wiersinga, W.J. & Boer, M.G.J. de (2022), Significant impact of vaccination on length of hospital stay and survival in hospitalized patients with COVID-19.
- Wymant, C.; Bezemer, D.; Blanquart, F.; Ferretti, L.; Gall, A.; Hall, M.; Golubchik, T.; Bakker, M.; Ong, S.H.; Zhao, L.; Bonsall, D.; Cesare, M. de; MacIntyre-Cockett, G.; Abeler-Dorner, L.; Albert, J.; Bannert, N.; Fellay, J.; Grabowski, M.K.; Gunsenheimer-Bartmeyer, B.; Gunthard, H.F.; Kivela, P.; Kouyos, R.D.; Laeyendecker, O.; Meyer, L.; Porter, K.; Ristola, M.; Sighem, A. van; Berkhout ben; Kellam, P.; Cornelissen, M.; Reiss, P.; Fraser, C.; Netherlands ATHENA HIV Observation & BEEHIVE Collaboration (2022), A highly virulent variant of HIV-1 circulating in the Netherlands, Science 375(6580): 540-+.
- Roukens, A.H.E.; Pothast, C.R.; Konig, M.; Huisman, W.; Dalebout, T.; Tak, T.; Azimi, S.; Kruize, Y.; Hagedoorn, R.S.; Zlei, M.; Staal, F.J.T.; Bie, F.J. de; Dongen, J.J.M. van; Arbous, S.M.; Zhang, J.L.H.; Verheij, M.; Prins, C.; Does, A.M. van der; Hiemstra, P.S.; Vries, J.J.C. de; Janse, J.J.; Roestenberg, M.; Myeni, S.K.; Kikkert, M.; Yazdanbakhsh, M.; Heemskerk, M.H.M.; Smits, H.H.; Jochems, S.P.; Collaboration BEAT-COVID Grp & Collaboration COVID-19 LUMC Grp (2022), Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8(+) T cell responses following COVID-19, Nature Immunology 23.
- Scheper, H. & Boer, M.G.J. de (2022), Rifampin for staphylococcal prosthetic joint infection: do we still need a randomized controlled trial?
- Eikenboom, A.M.; Cessie, S. le; Waernbaum, I.; Groenwold, R.H.H. & Boer, M.G.J. de (2022), Quality of conduct and reporting of propensity score methods in studies investigating the effectiveness of antimicrobial therapy, Open Forum Infectious Diseases 9(4).
- Smits, R.A.L.; Trompet, S.; Linden, C.M.J. van der; Bol, J.M. van der; Jansen, S.W.M.; Polinder-Bos, H.A.; Willems, H.C.; Barten, D.G.; Blomaard, L.C.; Boer, M.G.J. de; Deudekom, F.J.A. van; Ellerbroek, J.L.J.; Festen, J.; Glind, E.M.M. van de; Kampschreur, L.M.; Karimi, O.; Kroon, B.; Lanen, M.G.J.A. van; Lucke, J.A.; Maas, H.A.A.M.; Mattace-Raso, F.U.S.; Munster, B.C. van; Reijerse, L.; Robben, S.H.M.; Ruiter, R.; Schouten, H.J.; Spies, P.E.; Wassenburg, A.; Wijngaarden, M.A. & Mooijaart, S.P. (2022), Characteristics and outcomes of older patients hospitalised for COVID-19 in the first and second wave of the pandemic in The Netherlands, Age and Ageing 51(3).
- Eskenazi, A.; Lood, C.; Wubbolts, J.; Hites, M.; Balarjishvili, N.; Leshkasheli, L.; Askilashvili, L.; Kvachadze, L.; Noort, V. van; Wagemans, J.; Jayankura, M.; Chanishvili, N.; Boer, M. de; Nibbering, P.; Kutateladze, M.; Lavigne, R.; Merabishvili, M. & Pirnay, J.P. (2022), Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae, Nature Communications 13(1).
- Sieswerda, E.; Bax, H.I.; Hoogerwerf, J.J.; Boer, M.G.J. de; Boermeester, M.; Bonten, M.J.M.; Dekker, D.; Wijk, R.G. van; Juffermans, N.P.; Kuindersma, M.; Linden, P.D. van der; Melles, D.C.; Pickkers, P.; Schouten, J.A.; Rebel, J.R.; Zanten, A.R.H. van; Prins, J.M. & Wiersinga, W.J. (2022), The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults, BMC Infectious Diseases 22(1).
- Westgeest, A.C.; Schippers, E.F.; Sijbom, M.; Visser, L.G.; Boer, M.G.J. de; Numans, M.E.; Lambregts, M.M.C. & MRSA Network Holland West (2022), Exploring the barriers in the uptake of the Dutch MRSA 'search and destroy' policy using the cascade of care approach, Antibiotics 11(9).
- Scheper, H.; Wal, R.J.P. van der; Mahdad, R.; Keizer, S.; Delfos, N.M.; Lugt, J.C.T. van der; Veldkamp, K.E.; Nolte, P.A.; Leendertse, M.; Gelinck, L.B.S.; Mollema, F.P.N.; Schippers, E.F.; Wattel-Louis, H.G.; Visser, L.G.; Nelissen, R.G.H.H. & Boer, M.G.J. de (2022), Effectiveness of different antimicrobial strategies for staphylococcal prosthetic joint infection, Open Forum Infectious Diseases 9(10).
- Buis, D.T.P.; Prins, J.M.; Betica-Radic, L.; Boer, M.G.J. de; Ekkelenkamp, M.; Kofteridis, D.; Peiffer-Smadja, N.; Schouten, J.; Spernovasilis, N.; Tattevin, P.; Oever, J. ten; Sigaloff, K.C.E. & ESCMID Study Grp Antimicrobial Ste (2022), Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia, Journal of Antimicrobial Chemotherapy 77(10): 2827-2834.
- Sijbom, M.; Braun, K.K.; Buchner, F.L.; Bodegom-Vos, L. van; Hendriks, B.J.C.; Boer, M.G.J. de; Numans, M.E. & Lambregts, M.M.C. (2022), Cues to improve antibiotic-allergy registration, PLoS ONE 17(4).
- Hoogervorst, L.A.; Coul, L.S. op de; Ray, A.; Witte, P.B. de & Boer, M.G.J. de (2022), Mycetoma caused by Madurella mycetomatis in immunocompromised patients - a case report and systematic literature review, Journal of Bone and Joint Infection 7(6): 241-248.
- Hoogervorst, L.A.; Coul, L.S. op de; Ray, A.; Witte, P.B. de & Boer, M.G.J. de (2022), Mycetoma caused by Madurella mycetomatis in immunocompromised patients - a case report and systematic literature review, Journal of Bone and Joint Infection 7(6): 241-248.
- Sijbom, M.; Buechner, F.L.; Saadah, N.H.; Boer, M.G.D. & Numans, M.E. (2022), Comparing antibiotic prescriptions in primary care between SARS-CoV-2 and influenza, British Journal of General Practice Open 6(4).
- Smit, J.M.; Krijthe, J.H.; Tintu, A.N.; Endeman, H.; Ludikhuize, J.; Genderen, M.E. van; Hassan, S.; Moussaoui, R. el; Westerweel, P.E.; Goekoop, R.J.; Waverijn, G.; Verheijen, T.; Hollander, J.G. den; Boer, M.G.J. de; Gommers, D.A.M.P.J.; Vlies, R. van der; Schellings, M.; Carels, R.A.; Nieuwkoop, C. van; Arbous, S.M.; Bommel, J. van; Knevel, R.; Rijke, Y.B. de & Reinders, M.J.T. (2022), Development and validation of an early warning model for hospitalized COVID-19 patientscohort study, Intensive Care Medicine Experimental 10(1).
- Slim, M.A.; Appelman, B.; Peters-Sengers, H.; Dongelmans, D.A.; Keizer, N.F. de; Schade, R.P.; Boer, M.G.J. de; Mueller, M.C.A.; Vlaar, A.P.J.; Wiersinga, W.J. & Vught, L.A. van (2022), Real-world evidence of the effects of novel treatments for COVID-19 on mortality, Open Forum Infectious Diseases 9(12).
- Boer, M. G. J. de (2021), Antibioticakuur korter door procalcitonine-algoritme, Nederlands Tijdschrift voor Geneeskunde 166.
- Scheper, H.; Gerritsen, L.M.; Pijls, B.G.; Asten, S.A. van; Visser, L.G. & Boer, M.G.J. de (2021), Outcome of debridement, antibiotics, and implant retention for staphylococcal hip and knee prosthetic joint infections, focused on rifampicin use: a systematic review and meta-analysis, Open Forum Infectious Diseases 8(7).
- Westgeest, A.C.; Schippers, E.F.; Delfos, N.M.; Ellerbroek, L.J.; Koster, T.; Hira, V.; Visser, L.G.; Boer, M.G.J. de & Lambregts, M.M.C. (2021), Complicated carriage with methicillin-resistant Staphylococcus aureus, Antimicrobial Agents and Chemotherapy 65(9).
- Gerritsen, M.; Khawar, A.; Scheper, H.; Wal, R. van der; Schoones, J.; Boer, M. de; Nelissen, R. & Pijls, B. (2021), Modular component exchange and outcome of DAIR for hip and knee periprosthetic joint infection A SYSTEMATIC REVIEW AND META-REGRESSION ANALYSIS, Bone & Joint Open 2(10): 806-812.
- Peppel, R.J. van de; Grootveld, R. van; Hendriks, B.J.C.; Paassen, J. van; Bernards, S.; Jolink, H.; Koopmans, J.G.; Borne, P.A. von dem; Beek, M.T. van der & Boer, M.G.J. de (2021), Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance, Medical Mycology 60(1).
- Peppel, R.J. van de; Grootveld, R. van; Hendriks, B.J.C.; Paassen, J. van; Bernards, S.; Jolink, H.; Koopmans, J.G.; Borne, P.A. von dem; Beek, M.T. van der & Boer, M.G.J. de (2021), Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance, Medical Mycology 60(1).
- Laar, S.A. van; Boer, M.G.J. de; Gombert-Handoko, K.B.; Guchelaar, H.J.; Zwaveling, J. & LUMC-Covid-19 Res grp (2021), Liver and kidney function in patients with Covid-19 treated with remdesivir, British Journal of Clinical Pharmacology 87(11).
- Sieswerda, E.; Boer, M.G.J. de; Bonten, M.M.J.; Boersma, W.G.; Jonkers, R.E.; Aleva, R.M.; Kullberg, B.J.; Schouten, J.A.; Garde, E.M.W. van de; Verheij, T.J.; Eerden, M.M. van der; Prins, J.M. & Wiersinga, W.J. (2021), Recommendations for antibacterial therapy in adults with COVID-19-an evidence based guideline, Clinical Microbiology and Infection 27(1): 61-66.
- Smit, C.; Boyd, A.; Rijnders, B.J.A.; Laar, T.J.W. van de; Leyten, E.M.; Bierman, W.F.; Brinkman, K.; Claassen, M.A.A.; Hollander, J. den; Boerekamps, A.; Newsum, A.M.; Schinkel, J.; Prins, M.; Arends, J.E.; Coul, E.L.M. op de; Valk, M. van der; Reiss, P. & ATHENA Observational Cohort (2021), HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals, The Lancet HIV 8(2): E96-E105.
- Grootveld, R. van; Paassen, J. van; Boer, M.G.J. de; Claas, E.C.J.; Kuijper, E.J.; Beek, M.T. van der & LUMC-COVID-19 Research Grp (2021), Systematic screening for COVID-19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate, Mycoses 64(6).
- Lambregts, M.; Rump, B.; Ropers, F.; Sijbom, M.; Petrignani, M.; Visser, L.; Vries, M. de & Boer, M. de (2021), Antimicrobial guidelines in clinical practice, JAC-Antimicrobial Resistance 3(2).
- Groen, J.V.; Droogh, D.H.M.; Boer, M.G.J. de; Asten, S.A.V. van; Prehn, J. van; Inderson, A.; Vahrmeijer, A.L.; Bonsing, B.A. & Mieog, J.S.D. (2021), Clinical implications of bile cultures obtained during pancreatoduodenectomy, HPB 23(7): 1123-1133.
- Scheper, H.; Wubbolts, J.M.; Verhagen, J.A.M.; Visser, A.W. de; Wal, R.J.P. van der; Visser, L.G.; Boer, M.G.J. de & Nibbering, P.H. (2021), SAAP-148 eradicates MRSA persisters within mature biofilm models simulating prosthetic joint infection, Frontiers in Microbiology 12.
- Berghuis, D.; Lambregts, M.M.C. & Boer, M.G.J. de (2021), Taking a Rational Approach to a Reported Antibiotic Allergy, The Pediatric Infectious Disease Journal 40(5): S22-S25.
- Dijk, S.T. van; Abdulrahman, N.; Draaisma, W.A.; Enst, W.A. van; Puylaert, J.B.C.M.; Boer, M.G.J. de; Klarenbeek, B.R.; Otte, J.A.; Felt-Bersma, R.J.F.; Geloven, A.A.W. van & Boermeester, M.A. (2020), A systematic review and meta-analysis of disease severity and risk of recurrence in young versus elderly patients with left-sided acute diverticulitis, European Journal of Gastroenterology & Hepatology 32(5): 547-554.
- Overbosch, F.; Boer, M. de; Veldkamp, K.E.; Ellerbroek, P.; Bleeker-Rovers, C.P.; Goorhuis, B.; Vugt, M. van; Eijk, A. van der; Leenstra, T.; Khargi, M.; Ros, J.; Brandwagt, D.; Haverkate, M.; Swaan, C.; Reusken, C.; Timen, A.; Koopmans, M.; Dissel, J. van & Lassa Fever Response Team Netherla (2020), Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019, Eurosurveillance 25(15): 6-10.
- Visbeek, M.C.; Taljaard, J.J.; Boer, M.G.J. de; Cronje, U.J. & Steyn, E. (2020), Efficacy and patterns of use of antimicrobial prophylaxis for gunshot wounds in a South African hospital setting, South African Journal of Surgery 58(1): 27-32.
- Lambregts, M.M.C.; Molendijk, E.B.D.; Meziyerh, S.; Schippers, E.F.; Delfos, N.M.; Leendertse, M.; Bernards, A.T.; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2020), Early differentiation between uncomplicated and complicatedStaphylococcus aureusbacteraemia, International Journal of Clinical Practice 74(11).
- Wijnakker, R.; Lambregts, M.M.C.; Rump, B.; Veldkamp, K.E.; Reis, R.; Visser, L.G. & Boer, M.G.J. de (2020), Limited multi-drug resistant organism related stigma in carriers exposed to isolation precautions, Journal of Hospital Infection 106(1): 126-133.
- Lambregts, M.M.C.; Wijnakker, R.; Bernards, A.T.; Visser, L.G.; Cessie, S. le & Boer, M.G.J. de (2020), Mortality after delay of adequate empiric antimicrobial treatment of bloodstream infection, Journal of Clinical Medicine 9(5).
- Lambregts, M.M.C. & Boer, M.G.J. de (2020), Preoperative oral antibiotics in colon surgery.
- Peppel, R.J. van de; Schauwvlieghe, A.; Daele, R. van; Spriet, I.; van't Wout, J.W.; Bruggemann, R.J.; Rijnders, B.J.A.; Hendriks, B.J.C.; Boer, M.G.J. de & Dutch-Belgian Mycosis Study Grp (2020), Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B, Medical Mycology 58(7): 874-880.
- Groeneveld, G.H.; Marbus, S.D.; Ismail, N.; Vries, J.J. de; Schneeberger, P.; Oosterheert, J.J.; Dissel, J.T. van & Boer, M.G.J. de (2020), Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection, International Journal of Antimicrobial Agents 56(5).
- Chen, Q.G.; Toorop, M.M.A.; Boer, M.G.J. de; Rosendaal, F.R.; Lijfering, W.M. & LUMC-COVID-19 Res Grp (2020), Why crowding matters in the time of COVID-19 pandemic? , BMC Public Health 20(1).
- Vollaard, A.; Gieling, E. M.; Linden, P. D. van der; Sinha, B. & Boer, M. G. J. de (2020), Hydroxychloroquine en chloroquine bij COVID-19, Nederlands Tijdschrift voor Geneeskunde 164.
- Lambregts, M. M.; Hendriks, B. J.; Sijbom, M.; Sigaloff, K.; Nieuwhof, C. & Boer, M. G. de (2020), Kruisallergie van penicillines met cefalosporines, Nederlands Tijdschrift voor Geneeskunde 164.
- Boer, M. G. J. de; Gieling, E. M.; Linden, P. D. van der; Sinha, B. N. M. & Vollaard, A. M. (2020), Medicamenteuze behandeling van COVID-19, Nederlands Tijdschrift voor Geneeskunde 164.
- Chen, Q.G.; Toorop, M.M.A.; Boer, M.G.J. de; Rosendaal, F.R.; Lijfering, W.M. & LUMC-COVID-19 Res Grp (2020), Why crowding matters in the time of COVID-19 pandemic?, BMC Public Health 20(1).
- Wijnakker, R.; Lambregts, M.M.C.; Rump, B.; Veldkamp, K.E.; Reis, R.; Visser, L.G. & Boer, M.G.J. de (2020), Limited multi-drug resistant organism related stigma in carriers exposed to isolation precautions, Journal of Hospital Infection 106(1): 126-133.
- Lambregts, M.M.C.; Molendijk, E.B.D.; Meziyerh, S.; Schippers, E.F.; Delfos, N.M.; Leendertse, M.; Bernards, A.T.; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2020), Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia, International Journal of Clinical Practice 74(11).
- Scheper, H.; Derogee, R.; Mandad, R.; Wal, R.J.P. van der; Nelissen, R.G.H.H.; Visser, L.G. & Boer, M.G.J. de (2019), A mobile app for postoperative wound care after arthroplasty: Ease of use and perceived usefulness, International Journal of Medical Informatics 129: 75-80.
- Norgaard, S.M.; Jensen, C.S.; Aalestrup, J.; Vandenbroucke-Grauls, C.M.J.E.; Boer, M.G.J. de & Pedersen, A.B. (2019), Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review, Antimicrobial Resistance and Infection Control 8(1).
- Zoest, R.A. van; Law, M.; Sabin, C.A.; Vaartjes, I.; Valk, M. van der; Arends, J.E.; Reiss, P.; Wit, F.W.; Geerlings, S.E.; Godfried, M.H.; Goorhuis, A.; Hovius, J.W.; Kuijpers, T.W.; Nellen, F.J.B.; Poll, D.T. van der; Prins, J.M.; Vugt, H.J.M. van; Wiersinga, W.J.; Wit, F.W.M.N.; Duinen, M. van; Eden, J. van; Hes, A.M.H. van; Pijnappel, F.J.J.; Weijsenfeld, A.M.; Jurriaans, S.; Back, N.K.T.; Zaaijer, H.L.; Berkhout, B.; Cornelissen, M.T.E.; Schinkel, C.J.; Wolthers, K.C.; Peters, E.J.G.; Agtmael, M.A. van; Bomers, M.; Heitmuller, M.; Laan, L.M.; Ang, C.W.; Houdt, R. van; Pettersson, A.M.; Vandenbroucke-Grauls, C.M.J.E.; Berge, M. van den; Stegeman, A.; Baas, S.; Looff, L.H. de; Wintermans, B.; Veenemans, J.; Pronk, M.J.H.; Ammerlaan, H.S.M.; Munnik, E.S. de; Jansz, A.R.; Tjhie, J.; Wegdam, M.C.A.; Deiman, B.; Scharnhorst, V.; Eeden, A. van; Brokking, W.; Groot, M.; Elsenburg, L.J.M.; Damen, M.; Kwa, I.S.; Kasteren, M.E.E. van; Brouwer, A.E.; Erve, R. van; Kruijf-van de Wiel, B.A.F.M. de; Ven, B. van de; Buiting, A.G.M.; Kabel, P.J.; Versteeg, D.; Ende, M.E. van der; Bax, H.I.; Gorp, E.C.M. van; Nouwen, J.L.; Rijnders, B.J.A.; Schurink, C.A.M.; Verbon, A.; Vries-Sluijs, T.E.M.S. de; Jong-Peltenburg, N.C. de; Bassant, N.; Beek, J.E.A. van; Vriesde, M.; Zonneveld, L.M. van; Berg-Cameron, H.J. van den; Groot, J. de; Zeeuw-de Man, M. de; Boucher, C.A.B.; Koopmans, M.P.G.; Kampen, J.J.A. van; Pas, S.D.; Branger, J.; Douma, R.A.; Duijf-van de Ven, C.J.H.M.; Schippers, E.F.; Nieuwkoop, C. van; IJperen, J.M. van; Geilings, J.; Hut, G. van der; Burgel, N.D. van; Leyten, E.M.S.; Gelinck, L.B.S.; Davids-Veldhuis, S.; Hartingsveld, A.Y. van; Meerkerk, C.; Wildenbeest, G.S.; Heikens, E.; Groeneveld, P.H.P.; Bouwhuis, J.W.; Lammers, A.J.J.; Kraan, S.; Hulzen, A.G.W. van; Kruiper, M.S.M.; Bliek, G.L. van der; Bor, P.C.J.; Bloembergen, P.; Wolfhagen, M.J.H.M.; Ruijs, G.J.H.M.; Kroon, F.P.; Boer, M.G.J. de; Scheper, H.; Jolink, H.; Dorama, W.; Holten, N. van; Claas, E.C.J.; Wessels, E.; Hollander, J.G. den; Pogany, K.; Roukens, A.; Kastelijns, M.; Smit, J.V.; Smit, E.; Struik-Kalkman, D.; Tearno, C.; Niekerk, T. van; Pontesilli, O.; Lowe, S.H.; Lashof, A.M.L.O.; Posthouwer, D.; Ackens, R.P.; Burgers, K.; Schippers, J.; Weijenberg-Maes, B.; Loo, I.H.M. van; Havenith, T.R.A.; Mulder, J.W.; Vrouenraets, S.M.E.; Lauw, F.N.; Broekhuizen, M.C. van; Vlasblom, D.J.; Smits, P.H.M.; Weijer, S.; Moussaoui, R. el; Bosma, A.S.; Vonderen, M.G.A. van; Kampschreur, L.M.; Dijkstra, K.; Faber, S.; Weel, J.; Kootstra, G.J.; Delsing, C.E.; Burg-van de Plas, M. van der; Heins, H.; Kortmann, W.; Twillert, G. van; Renckens, R.; Ruiter-Pronk, D.; Truijen-Oud, F.A. van; Stuart, J.W.T.C.; IJzerman, E.P.; Jansen, R.; Rozemeijer; Reijden, W.A. van der; Brinkman, K.; Berk, G.E.L. van den; Blok, W.L.; Frissen, P.H.J.; Lettinga, K.D.; Schouten, W.E.M.; Veenstra, J.; Brouwer, C.J.; Geerders, G.F.; Hoeksema, K.; Kleene, M.J.; Meche, I.B. van der; Spelbrink, M.; Toonen, A.J.M.; Wijnands, S.; Kwa, D.; Regez, R.; Crevel, R. van; Keuter, M.; Ven, A.J.A.M. van der; Hofstede, H.J.M. ter; Dofferhoff, A.S.M.; Hoogerwerf, J.; Grintjes-Huisman, K.J.T.; Haan, M. de; Marneef, M.; Rahamat-Langendoen, J.; Stelma, F.F.; Burger, D.; Gisolf, E.H.; Hassing, R.J.; Claassen, M.; Beest, G. ter; Bentum, P.H.M. van; Langebeek, N.; Tiemessen, R.; Swanink, C.M.A.; Lelyveld, S.F.L. van; Soetekouw, R.; Prijt, L.M.M. van der; Swaluw, J. van der; Bermon, N.; Reijden, W.A. van der; Jansen, R.; Herpers, B.L.; Veenendaal, D.; Verhagen, D.W.M.; Wijk, M. van; Bierman, W.F.W.; Bakker, M.; Kleinnijenhuis, J.; Kloeze, E.; Stienstra, Y.; Wilting, K.R.; Wouthuyzen-Bakker, M.; Boonstra, A.; Meulen, P.A. van der; Weerd, D.A. de; Niesters, H.G.M.; Leer-Buter, C.C. van; Knoester, M.; Hoepelman, A.I.M.; Barth, R.E.; Bruns, A.H.W.; Ellerbroek, P.M.; Mudrikova, T.; Oosterheert, J.J.; Schadd, E.M.; Wassenberg, M.W.M.; Zoelen, M.A.D. van; Aarsman, K. & Elst-Laurijssen, D.H. (2019), Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV, Journal of Acquired Immune Deficiency Syndromes 81(5): 562-571.
- Lambregts, M.M.C.; Hendriks, B.J.C.; Visser, L.G.; Bernards, S.T. & Boer, M.G.J. de (2019), Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study, Antimicrobial Resistance and Infection Control 8.
- Gast, K.B.; Hoeven, A. van der; Boer, M.G.J. de; Esser, J.W.J. van; Kuijper, E.J.; Verweij, J.J.; Keulen, P.H.J. van & Beek, M.T. van der (2019), Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands, Medical Mycology Case Reports 24: 5-8.
- Sanders, P.T.J.; Bus, M.P.A.; Scheper, H.; Wal, R.J.P. van der; Sande, M.A.J. van de; Bramer, J.A.M.; Schaap, G.R.; Boer, M.G.J. de & Dijkstra, P.D.S. (2019), Multiflora and Gram-Negative Microorganisms Predominate in Infections Affecting Pelvic Endoprostheses Following Tumor Resection, Journal of Bone and Joint Surgery, American Volume 101(9): 797-803.
- Peppel, R.J. van de; Beek, M.T. van der; Visser, L.G.; Boer, M.G.J. de & Wallinga, J. (2019), Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies, International Journal of Antimicrobial Agents 53(3): 284-293.
- Rottier, S.J.; Dijk, S.T. van; Geloven, A.A.W. van; Schreurs, W.H.; Draaisma, W.A.; Enst, W.A. van; Puylaert, J.B.C.M.; Boer, M.G.J. de; Klarenbeek, B.R.; Otte, J.A.; Felt, R.J.F. & Boermeester, M.A. (2019), Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis, British Journal of Surgery 106(8): 988-997.
- Jonge, E. de; Boer, M.G.J. de; Essen, E.H.R. van; Dogterom-Ballering, H.C.M. & Veldkamp, K.E. (2019), Effects of a disinfection device on colonization of sink drains and patients during a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Journal of Hospital Infection 102(1): 70-74.
- Warreman, E.B.; Lambregts, M.M.C.; Wouters, R.H.P.; Visser, L.G.; Staats, H.; Dijk, E. van & Boer, M.G.J. de (2019), Determinants of in-hospital antibiotic prescription behaviour: a systematic review and formation of a comprehensive framework, Clinical Microbiology and Infection 25(5): 538-545.
- Newsum, A.M.; Kooij, K.W.; Boyd, A.; Smit, C.; Wit, F.W.N.M.; Meer, J.T.M. van der; Prins, M.; Reiss, P.; Valk, M. van der; Eden, H. van; Molenkamp, R.; Pijnappel, F.; Reesink, H.W.; Schinkel, J.; Steba, G.S.; Berk, G.E.L. van den; Brinkman, K.; Hooijenga, I.; Kwa, D.; Meche, N. van der; Toonen, A.; Vos, D.; Broekhuizen, M. van; Lauw, E.N.; Mulder, J.W.; Arend, J.E.; Kessel, A. van; Silvius, B.; Versloot, M.; Boonstra, A.; Rijnders, B.J.A.; Brokking, W.; Eeden, A. van; Elsenburg, L.; Nobel, H.E.; Laar, T.J.W. van de; Veldt, W. van der; Geerlings, S.E.; Goorhuis, A.; Hovius, J.W.; Lempkes, B.; Nellen, F.J.B.; Poll, T. van der; Prins, J.M.; Vugt, M. van; Wiersinga, W.J.; Duinen, M. van; Eden, J. van; Hazenberg, A.; Hes, A.M.H. van; Pijnappel, F.J.J.; Smalhout, S.Y.; Weijsenfeld, A.M.; Jurriaans, S.; Back, N.K.T.; Zaaijer, H.L.; Berkhout, B.; Cornelissen, M.T.E.; Schinkel, C.J.; Wolthers, K.C.; Peters, E.J.G.; Agtmael, M.A. van; Bomers, M.; Sigaloff, K.C.E.; Heitmuller, M.; Laan, L.M.; Ang, C.W.; Houdt, R. van; Jonges, M.; Pettersson, A.M.; Prehn, J. van; Berge, M. van den; Stegeman, A.; Baas, S.; Looff, L.H. de; Wintermans, B.; Veenemans, J.; Pronk, M.J.H.; Ammerloan, H.S.M.; Munnik, E.S. de; Jansz, A.R.; Tjhie, J.; Wegdam, M.C.A.; Deiman, B.; Scharnhorst, V.; Elsenburg, L.J.M.; Nobel, H.; Damen, M.; Kasteren, M.E.E. van; Berrevoets, M.A.H.; Brouwer, A.E.; Adams, A.; Kruijf-van de Wiel, B.A.E. de; Keelan-Pfaf, S.; Ven, B. van de; Ven, B. van der; Buiting, A.G.M.; Murck, J.L.; Versteeg, D.; Ende, M.E. van der; Box, H.I.; Gorp, E.C.M. van; Nouwen, J.L.; Schurink, C.A.M.; Verbon, A.; Vries-Sluijs, T.E.M.S. de; Jong-Peltenburg, N.C. de; Bassant, N.; Beek, J.E.A. van; Vriesde, M.; Zonneveld, L.M. van; Berg-Cameron, H.J. van den; Groot, J. de; Boucher, C.A.B.; Koopmans, M.P.G.; Kampen, J.J.A. van; Branger, J.; Douma, R.A.; Duijf-van de Ven, C.J.H.M.; Schippers, E.F.; Nieuwkoop, C. van; IJperen, J.M. van; Geilings, J.; Hut, G. van der; Burgel, N.D. van; Leyten, E.M.S.; Gelinck, L.B.S.; Mollema, F.; Davids-Veldhuis, S.; Hartingsveld, A.Y. van; Wildenbeest, G.S.; Heikens, E.; Groeneveld, P.H.P.; Bouwhuis, J.W.; Lammers, A.J.J.; Kraan, S.; Hulzen, A.G.W. van; Kruiper, M.S.M.; Bliek, G.L. van der; Bor, P.C.J.; Bloembergen, P.; Wolthagen, M.H.M.; Ruijs, G.J.H.M.; Kroon, E.; Boer, M.G.J. de; Scheper, H.; Jolink, H.; Dorama, W.; Holten, N. van; Claas, E.C.J.; Wessels, E.; Hollander, J.G. den; Pogany, K.; Roukens, A.; Douma, R.; Kastelijns, M.; Smit, J.V.; Smit, E.; Struik-Kalkman, D.; Tearno, C.; Niekerk, T. van; Pontesilli, O.; Lowe, S.H.; Lashof, A.M.L.O.; Posthouwer, D.; Ackens, R.P.; Burgers, K.; Schippers, J.; Enberg-Maes, B.W.; Loo, I.H.M. van; Havenith, T.R.A.; Vrouenraets, S.M.E.; Broekhuizen, M.C. van; Vlasblom, D.J.; Kroeze, M.; Smits, P.H.M.; Weijer, S.; Moussaoui, R. el; Bosma, A.S.; Vonderen, M.G.A. van; Kampschreur, L.M.; Faber, S.; Steeman-Bouma, R.; Wed, J.; Kootstra, G.J.; Delsing, C.E.; Burg-van de Plas, M. van der; Heins, H.; Kortmann, W.; Twillert, G. van; Renckens, R.; Ruiter-Pronk, D.; Truijen-Oud, E.A. van; Stuart, J.W.T.C.; Jansen, E.R.; Hoogewerf, M.; Rozemeijer, W.; Reijden, W.A. van der; Sinnige, J.C.; Blok, W.L.; Frissen, P.H.J.; Lettinga, K.D.; Schouten, W.E.M.; Veenstra, J.; Brouwer, C.J.; Geerders, G.E.; Hoeksema, K.; Kleene, M.J.; Knapen, M.; Meche, I.B. van der; Mulder-Seeleman, E.; Toonen, A.J.M.; Wijnands, S.; Crevel, R. van; Dofferhoff, A.S.M.; Hofstede, H.J.M. ter; Hoogerwerf, J.; Keuter, M.; Richel, O.; Albers, M.; Grintjes-Huisman, K.J.T.; Haan, M. de; Marneef, M.; Strik-Albers, R.; Rahamat-Langendoen, J.; Stelma, E.E.; Burger, D.; Gisolf, E.H.; Hassing, R.J.; Claassen, M.; Beest, G. ter; Bentum, P.H.M. van; Langebeek, N.; Tiemessen, R.; Swanink, C.M.A.; Lelyveld, S.F.L. van; Soetekouw, R.; Prijt, L.M.M. van der; Swaluw, J. van der; Bermon, N.; Jansen, R.; Herpers, B.L.; Veenendaal, D.; Verhagen, D.W.M.; Wijk, M. van; Bierman, W.F.W.; Bakker, M. & Kleinnij (2019), Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM, AIDS 33(5): 833-844.
- Peppel, R.J. van de & Boer, M.G.J. de (2019), The Complex Case of Aspergillus and Mortality, Clinical Infectious Diseases 68(3): 531-532.
- Lambregts, M.M.C.; Bernards, A.T.; Beek, M.T. van der; Visser, L.G. & Boer, M.G. de (2019), Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy, PLoS ONE 14(1).
- Lambregts, M.M.C.; Visser, L.G.; Boer, M.G.J. de; Staats, H. & Dijk, E. van (2019), 'Determinants of in-hospital antibiotic prescription behaviour' - Author's reply, Clinical Microbiology and Infection 25(5): 638-639.
- Gast, K.B.; Hoeven, A. van der; Boer, M.G.J. de; Esser, J.W.J. van; Kuijper, E.J.; Verweij, J.J.; Keulen, P.H.J. van & Beek, M.T. van der (2019), Two cases of Emergomyces pasteurianus infection in immunocompromised patients in the Netherlands, Medical Mycology Case Reports 24: 5-8.
- Peppel, R.J. van de & Boer, M.G.J. de (2019), The Complex Case of Aspergillus and Mortality, Clinical Infectious Diseases 68(3): 531-532.
- Grootveld, R. van; Bilsen, M.P.; Boelsums, T.L.; Heddema, E.R.; Groeneveld, G.H.; Gooskens, J. & Boer, M.G.J. de (2018), Chlamydia caviae Causing Community-Acquired Pneumonia: An Emerging Zoonosis, Vector-Borne and Zoonotic Diseases.
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Scheper, H.; Hooven, D. van; Sande, M. van de; Wal, R. van der; Beek, M. van der; Visser, L.; Boer, M. de & Nelissen, R. (2018), Outcome of acute staphylococcal prosthetic joint infection treated with debridement, implant retention and antimicrobial treatment with short duration of rifampicin, Journal of Infection 76(5): 498-500.
- Boer, M.G.J. de; Walzer, P.D. & Mori, S. (2018), Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention, Transplant Infectious Disease 20(5).
- Dijk, S.T. van; Bos, K.; Boer, M.G.J. de; Draaisma, W.A.; Enst, W.A. van; Felt, R.J.F.; Klarenbeek, B.R.; Otte, J.A.; Puylaert, J.B.C.M.; Geloven, A.A.W. van & Boermeester, M.A. (2018), A systematic review and meta-analysis of outpatient treatment for acute diverticulitis, International Journal of Colorectal Disease 33(5): 505-512.
- Scheper, H.; Holten, N. van; Hovens, J.G.F.M. & Boer, M.G.J. de (2018), Severe depression as a neuropsychiatric side effect induced by dolutegravir, HIV Medicine 19(4): E58-E59.
- Van der Hoeven A., Akerboom S., Norbart I., Van der Beek M. T., De Boer M. G. J. & Kuijper E. J. (2018), A fatal case of Emergomyces pasteurianus pulmonary infection in an immunocompromised patient with concomitant listeriosis and invasive aspergillosis, Medical Mycology 56: S103-S103.
- Peppel, R.J. van de; Visser, L.G.; Dekkers, O.M. & Boer, M.G.J. de (2018), The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review, Journal of Infection 76(6): 550-562.
- Lambregts, M.M.C.; Warreman, E.B.; Bernards, A.T.; Veelken, H.; Borne, P.A.V.; Dekkers, O.M.; Visser, L.G. & Boer, M.G. de (2018), Distribution and clinical determinants of time-to-positivity of blood cultures in patients with neutropenia, European Journal of Haematology 100(2): 206-214.
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Boer, M.G.J. de; Walzer, P.D. & Mori, S. (2018), Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention, Transplant Infectious Disease 20(5).
- Lambregts, M.M.C.; Bernards, A.T.; Visser, L.G. & Boer, M.G.J. de (2018), Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al., Clinical Microbiology and Infection 24(12): 1346-1348.
- Peppel, R.J. van de; Borne, P.A. von dem; Cessie, S. le & Boer, M.G.J. de (2017), A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short-but not on long-term survival of patients with AML or high-risk MDS, Bone Marrow Transplantation 52(6): 883-888.
- Henegouwen, J.M.V.; Groeneveld, G.H.; Boer, M.G.J. de & Visser, L.G. (2017), A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed, Netherlands Journal of Medicine 75(10): 462-463.
- Halem, K. van; Vrolijk, L.; Pereira, A.M. & Boer, M.G.J. de (2017), Characteristics and Mortality of Pneumocystis Pneumonia in Patients With Cushing's Syndrome: A Plea for Timely Initiation of Chemoprophylaxis, Open Forum Infectious Diseases 4(1).
- Rump, B.; Boer, M. de; Reis, R.; Wassenberg, M. & Steenbergen, J. van (2017), Signs of stigma and poor mental health among carriers of MRSA, Journal of Hospital Infection 95(3): 268-274.
- Boer, M.G.J. de & Brinkman, K. (2017), Recent observations on intolerance of dolutegravir: differential causes and consequences, AIDS 31(6): 868-870.
- Bolhuis, H. van; Wolters, M.; Boer, M. de; Fijnheer, R.; Langhout, M.V.; Niphuis, H. & Eckmann, C. (2017), Thrombotic thrombocytopenic purpura related to ADAMTS13 deficiency, and successful treatment in a chimpanzee (Pan troglodytes verus), Journal of Medical Primatology 46(5): 267-270.
- Ruiter, R.; Wunderink, H.F.; Veenendaal, R.A.; Visser, L.G. & Boer, M.G.J. de (2017), Helicobacter pylori resistance in the Netherlands: a growing problem?, Netherlands Journal of Medicine 75(9): 394-398.
- Creemers-Schild, D.; Kroon, F.P.; Kuijper, E.J. & Boer, M.G.J. de (2016), Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study, Infection 44(3): 291-299.
- Boer, M.G.J. de; Berk, G.E.L. van den; Holten, N. van; Oryszcyn, J.E.; Dorama, W.; Moha, D.A. & Brinkman, K. (2016), Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice, AIDS 30(18): 2831-2834.
- Creemers-Schild Dina, Kroon Frank P., Kuijper Ed. J. & de Boer Mark G. J. (2016), Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study, Infection 44(3): 291-299.
- Boer, M.C.; Prins, C.; Meijgaarden, K.E. van; Dissel, J.T. van; Ottenhoff, T.H.M. & Joosten, S.A. (2015), Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults, Clinical and Vaccine Immunology 22(7): 778-788.
- Peppel, R.J. van de; Borne, P.A.V.; Cessie, S. le & Boer, M.G.J. de (2015), A new time dependent analytical approach for assessment of the impact of Invasive Aspergillosis on short and long-term survival, Mycoses 58: 156-157.
- Diepen, A.T.N. van; Hoekstra, T.; Rotmans, J.I.; Boer, M.G.J. de; Cessie, S. le; Suttorp, M.M.; Struijk, D.G.; Boeschoten, E.W.; Krediet, R.T. & Dekker, F.W. (2014), The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infections, Nephrology Dialysis Transplantation 29(12): 2244-2250.
- Peppel, R.J. van de; Dekkers, O.M.; Borne, P.A. von dem & Boer, M.G.J. de (2014), Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome, Medical Mycology 52(7): 699-705.
- Diepen, A.T. van; Hoekstra, T.; Rotmans, J.I.; Boer, M.G. de; Lecessie, S.; Suttorp, M.M.; Struijk, D.G.; Boeschoten, E.W.; Krediet, R.T. & Dekker, F.W. (2014), FIRST DIALYSIS MODALITY AND THE RISK FOR DIALYSIS TECHNIQUE AND NON-DIALYSIS TECHNIQUE RELATED INFECTIONS, Nephrology Dialysis Transplantation 29: 274-274.
- Boer, M.G.J. de; Halkes, C.J.M. & Vosse, E.V. de (2014), PTX3 Deficiency and Aspergillosis, New England Journal of Medicine 370(17): 1665-1666.
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Knoester, M.; Boer, M.G.J. de; Maarleveld, J.J.; Claas, E.C.J.; Bernards, A.T.; Jonge, E.; Dissel, J.T. van & Veldkamp, K.E. (2014), An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit, Clinical Microbiology and Infection 20(4): O207-O215.
- Boer, M.G.J. de (2012), Linking Pneumocystis Epidemiology, Transmission, and Virulence.
- Boer, M.G.J. de (2012), Linking Pneumocystis Epidemiology, Transmission, and Virulence, Clinical Infectious Diseases 54(10): 1445-1447.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
- Lupetti, A.; Boer, M.G.J. de; Erba, P.; Campa, M. & Nibbering, P.H. (2011), Radiotracers for fungal infection imaging, Medical Mycology 49: S62S69.
- Boer, M.G.J. de; Gelinck, L.B.S.; Zelst, B.D. van; Sande, W.W.J. van de; Willems, L.N.A.; Dissel, J.T. van; Jonge, R. de & Kroon, F.P. (2011), beta-D-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study, Journal of Infection 62(1): 93-100.
- Boer, M.G.J. de; Jolink, H.; Halkes, C.J.M.; Heiden, P.L.J. van der; Kremer, D.; Falkenburg, J.H.F.; Vosse, E. van de & Dissel, J.T. van (2011), Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation, PLoS ONE 6(4).
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human beta-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, Journal of Infectious Diseases 203(5): 736-743.
- Boer, M.G.J. de; Fijter, J.W. de & Kroon, F.P. (2011), Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review, Medical Mycology 49(7): 673-680.
- Boer, M.G.J. de; Zelst, B. van; Gelinck, L.B.S.; Kroon, F.P. & Jonge, R. de (2011), Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels, Journal of Infection 62(6): 493-495.
- Boer, M.G.J. de; Gelinck, L.B.S.; Zelst, B.D. van; Sande, W.W.J. van de; Willems, L.N.A.; Dissel, J.T. van; Jonge, R. de & Kroon, F.P. (2011), β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study.
- Chai, L.Y.A.; Boer, M.G.J. de; Velden, W.J.F.M. van der; Plantinga, T.S.; Spriel, A.B. van; Jacobs, C.; Halkes, C.J.M.; Vonk, A.G.; Blijlevens, N.M.; Dissel, J.T. van; Donnelly, P.J.; Kullberg, B.J.; Maertens, J. & Netea, M.G. (2011), The Y238X Stop Codon Polymorphism in the Human β-Glucan Receptor Dectin-1 and Susceptibility to Invasive Aspergillosis, The Journal of Infectious Diseases 203(5): 736-743.
- Boer, M.G.J. de; Kroon, F.P.; Cessie, S. le; Fijter, J.W. de & Dissel, J.T. van (2011), Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis., Transplant Infectious Disease.
- Boer, M.G.J. de; Zelst, B. van; Gelinck, L.B.S.; Kroon, F.P. & Jonge, R. de (2011), Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels.
- Boer, M.G.J. de; Fijter, J.W. de & Kroon, F.P. (2011), Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review., Medical Mycology 49(7): 673-80.
- Boer, M.G.J. de; Wessels, E.; Claas, E.C.J. & Kroon, F.P. (2010), Potential Influence of More-Sensitive HIV-1 Load Detection by the new Roche Cobas AmpliPrep/Cobas TaqMan Version 2.0 Assay on Clinical Management of HIV-Positive Pregnant Women, Journal of Clinical Microbiology 48(11): 4301-4302.
- de Boer MGJ, Brunsveld-Reinders AH, Salomons EMA, Dijkshoorn L, Bernards AT, van den Berg PCM & van den Broek PJ (2008), Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU: Analysis of risk factors and epidemiological characteristics, Journal of Infection 56(6).
- Boer, M.G.J. de; Brunsveld-Reinders, A.H.; Salomons, E.M.A.; Dijkshoorn, L.; Bernards, A.T.; Berg, P.C.M. van den & Broek, P.J. van den (2008), Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU:: Analysis of risk factors and epidemiological characteristics, Journal of Infection 56(6): 446-453.
- de Boer MGJ, van Coppenraet LESB, Gaasbeek A, Berger SP, Gelinck LBS, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP & Vandenbroucke JP (2007), An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: Interhuman transmission or a common environmental source?, Clinical Infectious Diseases 44(9).
- Boer, M.G.J. de; Lambregts, P.C.L.A.; Dam, A.P. van & van't Wout, J.W. (2007), Meningitis caused by Capnocytophaga canimorsus:: When to expect the unexpected, Clinical Neurology and Neurosurgery 109(5): 393-398.
- Boer, M.G.J. de; Coppenraet, L.E.S.B. van; Gaasbeek, A.; Berger, S.P.; Gelinck, L.B.S.; Houwelingen, H.C. van; Broek, P. van den; Kuijper, E.J.; Kroon, F.P. & Vandenbroucke, J.P. (2007), An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients:: Interhuman transmission or a common environmental source?, Clinical Infectious Diseases 44(9): 1143-1149.
- Grunhagen, D.J.; Boer, M.G.J. de; Beaufort, A.J. de & Walther, F.J. (2002), Transepidermal water loss during halogen spotlight phototherapy in preterm infants, Pediatric Research 51(3).
- Grunhagen, D.J.; Boer, M.G.J. de; Beaufort, A.J. de & Walther, F.J. (2000), How much extra fluid intake is necessary during halogen spotlight phototherapy in preterm infants?, Pediatric Research 47(4): 288A-288A.
- Lid COIG (Cursorisch Onderwijs Interne Geneeskunde) infectieziekten (onderwijs)